# A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex

> **NCT00002004** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** CD4 Antigens

## Key facts

- **NCT ID:** NCT00002004
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002004, "A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00002004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*